The Online Investor
Biotechnology IPOs image Biotechnology IPOs » By The Online Investor Staff, updated Sun., Feb. 25, 8:18 PM
Recent initial public offerings in the Biotechnology IPOs category.

Slide #1. Cellect Biotechnology Ltd. Initial Public Offering

Company: Cellect Biotechnology Ltd.
Proposed Symbol: APOP
Shares Offered: 1,292,308
Price Per Share: $6.50
Over-Allotment: 193,846
Description: Cellect Biotechnology Ltd. (NASDAQ:APOP) (NASDAQ:APOPW) (TASE:CLBD), a developer of innovative technology which enables the functional selection of stem cells, today announced the pricing of its initial public offering in the United States of 1,292,308 American Depository Shares ("ADSs") and warrants to purchase up to 969,231 ADSs. Each ADS, representing 20 ordinary shares of the Company, and each warrant to purchase ADSs (in an amount equal to 75% of the ADSs purchased) are offered at a combined price to the public of $6.50. The warrants will have a per ADS exercise price of $7.50, are exercisable immediately, and will have a term of five years. The gross proceeds to Cellect from this offering are expected to be $8,400,000, prior to deducting underwriting discounts, commissions and other estimated offering expenses. Cellect has granted the underwriters a 45-day option to purchase up to an additional 193,846 ADSs and/or warrants to purchase 145,385 ADSs to cover over-allotments, if any.

IPOs: Cellect Biotechnology Ltd.

List of Biotechnology IPOs in this Slideshow: Company Ticker IPO Date Cancer Genetics, Inc. CGIX bluebird bio, Inc. BLUE 6/19/2013 NanoString Technologies, Inc. NSTG Intrexon Corporation XON Onconova Therapeutics, Inc. ONTX Veracyte, Inc. VCYT ADMA Biologics ADMA Sorrento Therapeutics, Inc. SRNE Oxford Immunotec Global PL OXFD Biocept, Inc. BIOC Genocea Biosciences, Inc. GNCA Applied Genetic Technologies CorporationAGTC Radius Health, Inc. RDUS VBL Therapeutics VBLT Cellectar Biosciences, Inc. CLRB Forward Pharma A/S FWP Atara Biotherapeutics, Inc. ATRA Proteon Therapeutics Inc. PRTO Coherus BioSciences, Inc. CHRS Juno Therapeutics JUNO Summit Therapeutics plc SMMT Cellectis CLLS Cidara Therapeutics, Inc. CDTX Adaptimmune Therapeutics plc ADAP NantKwest, Inc. NK Benitec Biopharma Limited BNTC REGENXBIO Inc. RGNX Aclaris Therapeutics, Inc. ACRS WAVE Life Sciences Ltd. WVE Mesoblast Limited MESO Editas Medicine, Inc. EDIT AveXis, Inc. AVXS Intellia Therapeutics, Inc. NTLA Syros Pharmaceuticals SYRS Cellect Biotechnology Ltd. APOP

Biotechnology IPOs Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2018, All Rights Reserved Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.